- JP-listed companies
- FRONTEO,Inc.
- Cash flow
FRONTEO,Inc. (2158) Cash flow
Market cap
¥23.5B
P/E ratio
156x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Depreciation & amortization | 588 | 884 | 1,039 | 1,015 | 817 | 843 | 814 | 861 | 763 | 681 | 345 | 376 |
| Cash from operations | 1,023 | 617 | -198 | 1,495 | 731 | -229 | 2,027 | 2,376 | -915 | 1,710 | 753 | 321 |
| Capital expenditures | -203 | -674 | -328 | -211 | -253 | -214 | -61 | -61 | -170 | -210 | -83 | -201 |
| Cash from investing | -1,417 | -4,711 | -1,643 | -709 | -966 | -785 | -348 | -618 | -625 | -182 | -254 | -2,549 |
| Payments for dividends | - | -106 | -107 | - | - | -114 | - | - | -275 | - | - | - |
| Repurchases of common stock | - | - | - | - | - | - | - | - | - | - | - | -200 |
| Proceeds from issuance of term debt, net | 800 | 3,762 | 1,856 | 200 | 400 | 300 | 2,533 | 800 | - | - | - | 1,000 |
| Repayments of term debt | -288 | -455 | -751 | -826 | -1,001 | -943 | -3,000 | -896 | -823 | -730 | -707 | -942 |
| Cash from financing | 1,680 | 3,214 | 4,564 | -139 | -1,012 | -1,553 | -53 | -1,460 | -606 | -34 | -913 | 1,336 |